Efficacy of Faslodex in Treatment of SLE Clinical, Serologic, and Molecular Studies

This study has been completed.
Sponsor:
Collaborator:
AstraZeneca
Information provided by:
The Center for Rheumatic Disease, Allergy, & Immunology
ClinicalTrials.gov Identifier:
NCT00417430
First received: December 28, 2006
Last updated: September 18, 2009
Last verified: September 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2006
  Primary Completion Date: December 2006 (Final data collection date for primary outcome measure)